儿童FNH与肝腺瘤的多模态影像鉴别
本文讨论儿童局灶性结节性增生与肝腺瘤的临床病程、多模态影像表现及其对临床决策的影响。重点阐述肝胆特异性MRI对比剂在鉴别二者中的关键作用,同时指出其局限性与判读陷阱。
要点
- FNH与肝腺瘤多呈良性病程,但可增大或类似恶性,需个体化影像随访与管理。
- 肝腺瘤需警惕恶性转化及出血/破裂风险。
- 肝胆特异性MRI对比剂是鉴别FNH与肝腺瘤的关键工具,但存在判读陷阱。
核心结论
- 儿童FNH与肝腺瘤通常为良性病程,但需针对性影像随访与管理,因其可增大或类似恶性。
- 肝腺瘤的核心风险为恶性转化及肿瘤出血/破裂。
- 肝胆特异性MRI对比剂在鉴别FNH与肝腺瘤中发挥关键作用,但存在局限性与判读陷阱。
研究设计与样本
- 本文为影像学综述,讨论儿童FNH与肝腺瘤的多模态影像特征及临床决策影响。
关键影像表现/征象
- FNH与肝腺瘤在多模态影像上具有各自典型表现,需综合评估以与恶性病变区分。
- 肝胆特异性MRI对比剂可提供关键鉴别信息,但有潜在判读陷阱。
临床应用与阅片要点
- 阅片时应综合多模态影像表现,避免对可良性病变进行不必要活检。
- 使用肝胆特异性MRI对比剂时需注意其局限性与可能出现的判读陷阱。
- 对疑似肝腺瘤的患儿,应关注恶性转化及出血/破裂相关影像征象。
局限性
- 肝胆特异性MRI对比剂在鉴别诊断中存在局限性及潜在判读陷阱。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Radiological characterisation of liver tumours in children aims to differentiate benign from malignant or potentially malignant lesions, and where possible, obviate the need for biopsy. This approach aims to reduce unnecessary morbidity and parental/patient anxiety and promotes judicious use of radiological and surgical resources. Focal nodular hyperplasia (FNH) and hepatic adenoma usually have a benign course but require tailored imaging follow-up and management due to their propensity to enlarge and/or mimic malignancy. In the case of hepatic adenoma, malignant transformation and tumour haemorrhage/rupture are the key concerns. This paper will discuss the clinical course of these two entities, their typical imaging findings on a range of modalities and how this impacts decision-making at the clinical level. The utility of hepatobiliary-specific MRI contrast agents will be discussed with reference to their key role in differentiating FNH from hepatic adenoma, whilst highlighting limitations and potential interpretation pitfalls.
引用
- Ashworth, Chambers. Differentiating focal nodular hyperplasia from hepatic adenoma using a multimodality approach in children. Pediatr Radiol. 2026. PMID: 42541546. doi:10.1007/s00247-026-06743-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。